Dividend Stocks

The Dividend Daily

Dividend stocks - News, notes, updates, and analysis, delivered fresh daily

Tyson Foods Q4 Profit Beats Estimates, but Revenue Misses; Forecast In-Line (TSN)

Poultry producer Tyson Foods, Inc. (TSN) on Friday posted mixed fiscal first quarter earnings results, as profit beat Wall Street’s view but revenue fell short of expectations.

The Springdale, AR-based company reported fiscal first quarter net income of $173 million, or 48 cents per share, compared with $156 million, or 42 cents per share, in the year-ago period.

Revenue rose less than 1% from last year to $8.40 billion.

On average, Wall Street analysts expected a smaller profit of 42 cents per share, albeit on higher revenue of $8.60 billion.

CEO Donnie Smith commented, “We knew we’d face headwinds, and that has certainly been the case; however, we’re not simply holding our own. We’re producing solid results while preparing for growth.”

Accordingly, TSN forecast full-year fiscal 2013 revenue to hit $35 billion, which is in-line with analysts’ outlook of $34.65 billion.

Tyson Foods shares rose 58 cents, or +2.6%, in premarket trading Friday. The stock has gained over 17% in the past year.

The Bottom Line
Shares of TSN currently offer a 0.9% dividend yield, based on Thursday’s closing price of $22.12 and the company’s annualized dividend payout of 20 cents per share.

Tyson Foods, Inc. (TSN) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

5 Rules of Winning Dividend Investing

FREE Dividend Stock Newsletter

Get the Dividend.com email newsletter to receive:

  • A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
  • Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
  • Tons of great market analysis and recommendations

Your Email

Free Dividend Newsletter

Get free dividend tips, analysis and updates straight to your inbox

Comments on this Article COMMENTS ON THIS ARTICLE

Comments are closed.

About This Article ABOUT THIS ARTICLE

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Disclaimer: Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.